|
PLS3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.99999999953116E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.37830000044448E-07 |
| Normal-vs-Stage2 |
9.715400E-01 |
| Normal-vs-Stage3 |
2.04149999999403E-05 |
| Normal-vs-Stage4 |
1.009870E-04 |
| Stage1-vs-Stage2 |
2.904900E-03 |
| Stage1-vs-Stage3 |
7.112800E-01 |
| Stage1-vs-Stage4 |
5.317800E-01 |
| Stage2-vs-Stage3 |
2.020100E-03 |
| Stage2-vs-Stage4 |
1.955200E-03 |
| Stage3-vs-Stage4 |
7.394200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.45979999999213E-06 |
| Normal-vs-AfricanAmerican |
4.761600E-03 |
| Normal-vs-Asian |
1.152030E-04 |
| Caucasian-vs-AfricanAmerican |
1.439030E-01 |
| Caucasian-vs-Asian |
9.191500E-02 |
| AfricanAmerican-vs-Asian |
8.821200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.361070E-03 |
| Normal-vs-Female |
1.76310000044033E-07 |
| Male-vs-Female |
2.566600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.92640000027534E-07 |
| Normal-vs-Age(41-60Yrs) |
1.81399999998888E-06 |
| Normal-vs-Age(61-80Yrs) |
1.000160E-01 |
| Normal-vs-Age(81-100Yrs) |
1.196580E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.147000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.179810E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.427600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.472300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.443000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.669830E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.578200E-02 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
1.442240E-01 |
| Classical-VS-Normal |
2.52390330857111E-11 |
| Tall-VS-Follicular |
4.56301663120939E-14 |
| Tall-VS-Other |
2.431900E-02 |
| Tall-VS-Normal |
2.90629999954994E-07 |
| Follicular-VS-Other |
7.340400E-02 |
| Follicular-VS-Normal |
2.822500E-03 |
| Other-VS-Normal |
6.326400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.204200E-02 |
| Normal-vs-N1 |
1.217210E-03 |
| N0-vs-N1 |
3.751500E-02 |
|
|
